-
Tris Pharma expands retrieval of potentially dangerous infants' ibuprofen
fiercepharma
February 24, 2019
Tris Pharma, which first recalled potentially harmful infants' ibuprofen in December, is adding lots to the recall.
-
Extended recall of ibuprofen oral suspension drops
europeanpharmaceuticalreview
February 01, 2019
The recall of specific batches of children’s ibuprofen has been extended by the manufacture of the product as it has a greater concentration of ibuprofen…
-
Tris Pharma Issues Recall of Infants' Ibuprofen Concentrated Oral Suspension
americanpharmaceuticalreview
December 06, 2018
Tris Pharma, Inc. has voluntarily recalled three (3) lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level.....
-
AiPing Pharmaceutical Strikes Ibuprofen Deal with Xinhua Pharmaceutical
pharmafocusasia
November 29, 2018
AiPing Pharmaceutical, Inc. announced today that it has completed the sale of three ibuprofen Abbreviated New Drug Applications (ANDAs) in the U.S. to Shandong Xinhua Pharmaceutical Co., Ltd. AiPing will retain sales and distribution rights in the U.S.
-
Strides Shasun’s generic Ibuprofen receives USFDA approval
biospectrumasia
April 03, 2018
The company's product is a generic version of Pfizer Inc's Advil Liqui-Gels 200 mg
-
Ibuprofen better choice over oral morphine for pain relief in children
europeanpharmaceuticalreview
October 11, 2017
Widely available ibuprofen is a better choice for pain relief in children who have undergone minor surgery, as it has fewer adverse effects compared with oral morphine…